What’s the next CGM step change, and how is Dexcom going to deliver it? That’s one of the fundamental questions Jake Leach has been asked since stepping into the role of CEO at Dexcom. “I want to make ...
During Dexcom Investor Day, CEO Jake Leach announced the company's newest CGM monitor, G8, which utilizes technology that ...
Sell in May and Go Away-Starting With These 3 Stocks DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range ...
This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system.
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
On May 14, 2026, Dexcom held its 2026 Investor Day in Mesa, Arizona, where it outlined market opportunities, business strategy, innovation priorities, and a long-term financial outlook. The company ...
TORONTO--(BUSINESS WIRE)--Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results